Clinical Trials Logo

Neuroprotective clinical trials

View clinical trials related to Neuroprotective.

Filter by:
  • None
  • Page 1

NCT ID: NCT03169881 Active, not recruiting - Neonatal Clinical Trials

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

Darbe
Start date: September 20, 2017
Phase: Phase 3
Study type: Interventional

Study Hypothesis: Preterm infants administered weekly Darbe during the neonatal period will have improved neurocognitive outcome at 22-26 months compared to placebo